BioHarvest Sciences (BHST) Competitors $6.53 +0.09 (+1.40%) As of 10:35 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BHST vs. ETON, PRTC, SANA, MREO, ERAS, ZVRA, TECX, SNDL, ALT, and RAPPShould you be buying BioHarvest Sciences stock or one of its competitors? The main competitors of BioHarvest Sciences include Eton Pharmaceuticals (ETON), PureTech Health (PRTC), Sana Biotechnology (SANA), Mereo BioPharma Group (MREO), Erasca (ERAS), Zevra Therapeutics (ZVRA), Tectonic Therapeutic (TECX), SNDL (SNDL), Altimmune (ALT), and Rapport Therapeutics (RAPP). These companies are all part of the "pharmaceutical products" industry. BioHarvest Sciences vs. Eton Pharmaceuticals PureTech Health Sana Biotechnology Mereo BioPharma Group Erasca Zevra Therapeutics Tectonic Therapeutic SNDL Altimmune Rapport Therapeutics BioHarvest Sciences (NASDAQ:BHST) and Eton Pharmaceuticals (NASDAQ:ETON) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, community ranking, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends. Does the MarketBeat Community favor BHST or ETON? Eton Pharmaceuticals received 95 more outperform votes than BioHarvest Sciences when rated by MarketBeat users. However, 100.00% of users gave BioHarvest Sciences an outperform vote while only 65.77% of users gave Eton Pharmaceuticals an outperform vote. CompanyUnderperformOutperformBioHarvest SciencesOutperform Votes3100.00% Underperform VotesNo VotesEton PharmaceuticalsOutperform Votes9865.77% Underperform Votes5134.23% Is BHST or ETON more profitable? Eton Pharmaceuticals has a net margin of -15.81% compared to BioHarvest Sciences' net margin of -76.65%. BioHarvest Sciences' return on equity of 0.00% beat Eton Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets BioHarvest Sciences-76.65% N/A -85.16% Eton Pharmaceuticals -15.81%-36.29%-16.84% Which has more volatility and risk, BHST or ETON? BioHarvest Sciences has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, Eton Pharmaceuticals has a beta of 1.34, suggesting that its stock price is 34% more volatile than the S&P 500. Do analysts recommend BHST or ETON? BioHarvest Sciences currently has a consensus price target of $13.00, suggesting a potential upside of 99.08%. Eton Pharmaceuticals has a consensus price target of $27.67, suggesting a potential upside of 66.42%. Given BioHarvest Sciences' higher probable upside, equities analysts plainly believe BioHarvest Sciences is more favorable than Eton Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Eton Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor BHST or ETON? In the previous week, Eton Pharmaceuticals had 10 more articles in the media than BioHarvest Sciences. MarketBeat recorded 13 mentions for Eton Pharmaceuticals and 3 mentions for BioHarvest Sciences. Eton Pharmaceuticals' average media sentiment score of 0.94 beat BioHarvest Sciences' score of 0.47 indicating that Eton Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioHarvest Sciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Eton Pharmaceuticals 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in BHST or ETON? 27.9% of Eton Pharmaceuticals shares are held by institutional investors. 14.9% of Eton Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has higher valuation & earnings, BHST or ETON? Eton Pharmaceuticals has higher revenue and earnings than BioHarvest Sciences. Eton Pharmaceuticals is trading at a lower price-to-earnings ratio than BioHarvest Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioHarvest Sciences$25.19M4.26-$12.56M-$0.72-9.07Eton Pharmaceuticals$39.01M11.43-$940K-$0.15-110.83 SummaryEton Pharmaceuticals beats BioHarvest Sciences on 13 of the 17 factors compared between the two stocks. Get BioHarvest Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for BHST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHST vs. The Competition Export to ExcelMetricBioHarvest SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$107.26M$6.72B$5.49B$7.97BDividend YieldN/A3.05%5.11%4.23%P/E Ratio-5.237.3622.6118.58Price / Sales4.26241.71397.51103.15Price / CashN/A65.8538.1834.62Price / Book-6.056.486.704.26Net Income-$12.56M$143.43M$3.22B$248.31M7 Day Performance-1.06%1.69%1.26%1.34%1 Month Performance0.62%6.58%3.73%3.92%1 Year PerformanceN/A-2.63%15.82%5.33% BioHarvest Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHSTBioHarvest SciencesN/A$6.53+1.4%$13.00+99.1%N/A$107.26M$25.19M-5.23N/AETONEton Pharmaceuticals2.5404 of 5 stars$15.82+0.2%$27.67+74.9%+381.4%$424.26M$39.01M-71.9120Upcoming EarningsAnalyst RevisionNews CoveragePRTCPureTech Health2.1948 of 5 stars$17.26+0.7%$45.00+160.7%-38.1%$414.57M$3.33M0.00100News CoverageSANASana Biotechnology1.9119 of 5 stars$1.77flat$10.80+510.2%-78.9%$398.29MN/A-1.26380Upcoming EarningsMREOMereo BioPharma Group2.3399 of 5 stars$2.50-1.6%$7.71+208.6%-15.1%$397.50M$1M-41.6740High Trading VolumeERASErasca2.9745 of 5 stars$1.39-0.7%$4.83+247.7%-27.4%$393.74MN/A-1.67120Analyst ForecastPositive NewsZVRAZevra Therapeutics2.7655 of 5 stars$7.20-0.6%$22.29+209.5%+60.0%$393.69M$23.61M-3.6520Upcoming EarningsNews CoveragePositive NewsTECXTectonic Therapeutic2.546 of 5 stars$21.09-5.8%$72.40+243.3%N/A$393.60MN/A-3.58120Upcoming EarningsShort Interest ↑Gap DownSNDLSNDL3.0548 of 5 stars$1.49+0.7%$3.63+143.3%-39.7%$391.54M$920.45M-4.81580ALTAltimmune2.5889 of 5 stars$5.07-1.9%$20.83+310.9%-19.8%$390.46M$20,000.00-3.2750Upcoming EarningsNews CoveragePositive NewsRAPPRapport Therapeutics2.442 of 5 stars$10.62-4.3%$32.67+207.6%N/A$387.59MN/A-0.77N/A Related Companies and Tools Related Companies Eton Pharmaceuticals Competitors PureTech Health Competitors Sana Biotechnology Competitors Mereo BioPharma Group Competitors Erasca Competitors Zevra Therapeutics Competitors Tectonic Therapeutic Competitors SNDL Competitors Altimmune Competitors Rapport Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BHST) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BHST Stock Free BHST Stock Alerts